In DSM’s 2019 results, the company reported a net profit of EUR 764 m. Adjusted net profit was up EUR 830 m, up 8 % versus underlying business in 2018. The company expects to deliver a mid-single-digit increase in adjusted Ebitda for 2020 compared to prior year, together with an improvement in its adjusted net operating free cash flow in line with Strategy 2021 targets. This outlook is driven by DSM’s own growth initiatives, innovation programmes and self-help actions, and does not assume any significant improvement to the current macroeconomic environment.

As announced last December, DSM CEO Feike Sijbesma will hand over his responsibilities to his managing board colleagues Geraldine Matchett and Dimitri de Vreeze as Co-CEOs on 15 February 2020 and will support the transition until 1 May 2020.